Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

8 treatments under study, led by 08 Lugols Solution

Related Conditions

Often studied with 12 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
Phase 2 (1)

Trial Status

Completed2
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07390162Not ApplicableNot Yet Recruiting

The Effect of Changes in the Frequency of Endotracheal Tube Repositioning in Intensive Care Units on the Prevention of Oral Mucosal Pressure Injuries

NCT06020638Not ApplicableCompleted

Determining The Effects Of Nasopharyngeal Suction

NCT03180944Phase 2CompletedPrimary

Lower Lugol's Solution Concentration on Reducing the Adverse Symptoms of Chromoendoscopy With Iodine Staining

Showing all 3 trials

Research Network

Common Treatments

  • 08 Lugols Solution1
  • 10 Lugols Solution1
  • 04 Lugols Solution1
  • Experimental Group1
  • 06 Lugols Solution1

Active Sponsors

  • Shandong University1
  • Hacettepe University1
  • Fenerbahce University1

Top Investigators

Related Conditions

  • Mucosal Erosion1
  • Image Quality1
  • Pain1
  • Intensive Care Units Icus1
  • Adult Patients1

Activity Timeline